This GLP-1 stock has bigger opportunities to boost its share price
Instead of betting on which single pharmaceutical company wins a drug race, West Pharmaceutical Services benefits as the industry grows...
HEALTH & FITNESS
GLP-1 drugs for employees cost $250M a year
Brian Moynihan, CEO of Bank of America, speaking to CNBC from Aspen, Co. on Aug. 5th, 2026.CNBCBank of America spends...
Eli Lilly (LLY) earnings Q2 2026
Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook, as demand...
Novo Nordisk stock falls as raised outlook fails to change the debate over obesity business
Novo Nordisk's quarterly beat and guidance increase did little to resolve Wall Street's biggest concern: whether the Ozempic maker has...
Novo Nordisk releases earnings and guidance
Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in Copenhagen, Denmark,...
Merck (MRK) earnings Q2 2026
The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024.Spencer Platt | Getty...
New Medicaid work rules could leave rare disease patients uninsured
CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance...
Novo Nordisk shares dive after heart medicine fails trial
Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart drug trial...
AI stocks rebound, and why J&J’s earnings guidance cut is not cause for concern
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time...
Novo Nordisk sued by shareholders over weight-loss drug: What to know
A federal judge on Tuesday allowed parts of that lawsuit to move forward, finding that investors had plausibly alleged that...
Jim Cramer says Wall Street is fleeing the AI trade and buying these stocks instead
CNBC's Jim Cramer said Tuesday that Wall Street is taking profits in this year's biggest AI infrastructure winners and rotating...
McConnell not cleared for Senate return, continues recovery: Doctors
Senator Mitch McConnell and Secretary Elaine Chao on Sunday, July 26, 2026.Source: Office of Mitch McConnell.Sen. Mitch McConnell is recovering...
FedEx is chasing the GLP-1 boom. Why healthcare logistics means big business
The boom in GLP-1 weight-loss drugs and other specialized medicines has created lucrative logistics opportunities in an industry that pays...
Here are 4 forces that drove a tough week for stocks
It was a tough week for stocks, as investors navigated everything from escalating tensions in the Middle East to key...
CDC says outbreak is in nine states
A customer shops for cilantro at a Walmart Supercenter on July 23, 2026 in Austin, Texas. Brandon Bell | Getty...
Cyclospora outbreak tests RFK Jr. response, funding cuts
Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS), during a celebration at the Health and Human...
Eli Lilly will file for approval of retatrutide obesity drug in 2027
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025.Mike Blake | ReutersEli Lilly...
What it means for patients, drugmakers and prices
President Donald Trump's proposed tariffs on imported generic medicines have raised fresh questions about whether low-cost drugmakers can shift production...
Cardinal Health’s latest deals won’t move the needle. They still matter.
Cardinal Health announced two acquisitions Monday that could supercharge one of the fastest-growing parts of its business: home care. The...
Novo Nordisk sues Eli Lilly over GLP-1 ads
Photo illustration of a group of weight loss medications on a white background.Ucg | Universal Images Group | Getty ImagesNovo...
